Infographic – Biotech Index Plunge Continues in Q1

Click on image for full-size view (Nasdaq)

9 Apr. 2022. Our last look at the Nasdaq Biotechnology Index for 2021 showed NBI dropping from its high points in August and September 2021 to about where it started in January of that year. For the first three months of 2022, that drop in the NBI, an indicator of investor sentiment in the industry, continued through most of the quarter.

NBI opened on 3 Jan. 2022 at 4,728 and began a sharp decline to under 4,000 near the end of January. The index then rose slightly in early February, but began declining again until it reached its low point for the quarter at 3,827 on 14 Mar. Since mid-March, NBI is experiencing a rebound of sorts, closing yesterday at 4,277.

Since the beginning of 2022, NBI has declined about 10 percent. For comparison, the Nasdaq Composite Index, an indicator of overall technology industry investor sentiment, declined about 13 percent. NBI calculates the index from share prices of 370 biotechnology, analytics, and pharmaceutical companies.

More from Science & Enterprise:

• Infographic – Corp. Venture Funding Leaps in 2021
• Advanced Tech Venture Funds Raise $365 Million
• Infographic – Venture Funds More Than Double in 2021

We designed Science & Enterprise for busy readers including investors, researchers, entrepreneurs, and students. Except for a narrow cookies and privacy strip for first-time visitors, we have no pop-ups blocking the page, nor distracting animated GIF graphics. If you want to subscribe for daily email alerts, you can do that here, or find the link in the upper left-hand corner of the desktop page. The site is free, with no paywall. But, of course, donations are gratefully accepted.

*     *     *